Literature DB >> 30447227

Pediatric Oral Formulations: An Updated Review of Commercially Available Pediatric Oral Formulations Since 2007.

Robert G Strickley.   

Abstract

Oral pediatric formulations are either ready-to-use or require manipulation and multiuse or single-use. Strong encouragement for preservative-free pediatric formulations has resulted in fewer multiuse solutions or suspensions in favor of single-use solid oral dosage forms. This updated review covering new pediatric formulations marketed in the United States of America, Europe, and Japan spanning the years 2007 to mid-2018 identified 16 types of pediatric oral formulations of which 7 are ready-to-use and 9 require manipulation, and 51 total new pediatric oral formulations of which 21 are ready-to-use and 30 require manipulation. Ready-to-use formulations include oral solution, oral suspension, oral soluble film, tablet, scored tablets, orally disintegrating tablet, chewable tablet, and mini-tablets. Formulations requiring manipulation include sprinkle capsule, powder for oral solution, powder for oral suspension, granules for oral suspension, oral powder, oral granules, tablet, dispersible tablet, dispersible scored tablet, tablet for oral suspension, and mini-tablets (oral granules). Significant advances in packaging technology include filling mini-tablets, granules, or powders into sachets, stick packets, blisters, and 2-piece capsules. The future of pediatric oral formulations will increasingly be with user-friendly, preservative-free, taste-masked formulations including multiparticulate single-use solid dosage forms including mini-tablets, orally disintegrating tablets, and sprinkle capsules with or without a specialized package configuration.
Copyright © 2019 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Keywords:  excipient(s); formulation; oral drug delivery; pediatric

Mesh:

Substances:

Year:  2018        PMID: 30447227     DOI: 10.1016/j.xphs.2018.11.013

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  17 in total

Review 1.  Challenges and opportunities to include patient-centric product design in industrial medicines development to improve therapeutic goals.

Authors:  Carsten Timpe; Sven Stegemann; Andrew Barrett; Siddharthya Mujumdar
Journal:  Br J Clin Pharmacol       Date:  2020-06-16       Impact factor: 4.335

2.  On the Design of Food Effect Studies in Adults for Extrapolating Oral Drug Absorption Data to Infants: an Exploratory Study Highlighting the Importance of Infant Food.

Authors:  Marina Statelova; Konstantinos Goumas; Nikoletta Fotaki; René Holm; Mira Symillides; Christos Reppas; Maria Vertzoni
Journal:  AAPS J       Date:  2019-12-02       Impact factor: 4.009

3.  Systematic Studies on Surface Erosion of Photocrosslinked Polyanhydride Tablets and Data Correlation with Release Kinetic Models.

Authors:  Armin Geraili; Kibret Mequanint
Journal:  Polymers (Basel)       Date:  2020-05-12       Impact factor: 4.329

4.  Does the EU's Paediatric Regulation work for new medicines for children in Denmark, Finland, Norway and Sweden? A cross-sectional study.

Authors:  Pirkko Lepola; Siri Wang; Ann Marie Tötterman; Ninna Gullberg; Kirstine Moll Harboe; Elin Kimland
Journal:  BMJ Paediatr Open       Date:  2020-12-30

5.  Randomised comparative trial of the efficacy of paracetamol syrup and dispersible tablets for the treatment of fever in children.

Authors:  Benjamin Okereke; Okezie Ibeleme; Adaobi Bisi-Onyemaechi
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

6.  Assessment of Mini-Tablets Coating Uniformity as a Function of Fluid Bed Coater Inlet Conditions.

Authors:  Magdalena Turk; Rok Šibanc; Rok Dreu; Maja Frankiewicz; Małgorzata Sznitowska
Journal:  Pharmaceutics       Date:  2021-05-18       Impact factor: 6.321

7.  Comparison of Different Liquid and Semisolid Vehicles Selected for Oral Administration of Pellets and Minitablets with Diazepam: In Vitro Investigation.

Authors:  Hanna Kotlowska; Marta Szymanska; Malgorzata Sznitowska
Journal:  AAPS PharmSciTech       Date:  2020-07-31       Impact factor: 3.246

8.  Solid Dosage Forms of Dexamethasone Sodium Phosphate Intended for Pediatric Use: Formulation and Stability Studies.

Authors:  Maria S Synaridou; Eleftherios G Andriotis; Constantinos K Zacharis; Dimitrios G Fatouros; Catherine K Markopoulou
Journal:  Pharmaceutics       Date:  2020-04-14       Impact factor: 6.321

Review 9.  Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019.

Authors:  Jose-Manuel delMoral-Sanchez; Isabel Gonzalez-Alvarez; Marta Gonzalez-Alvarez; Andres Navarro-Ruiz; Marival Bermejo
Journal:  Pharmaceutics       Date:  2020-04-01       Impact factor: 6.321

10.  Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool.

Authors:  Jennifer Walsh; Tiziana Masini; Benedikt D Huttner; Lorenzo Moja; Martina Penazzato; Bernadette Cappello
Journal:  Pharmaceutics       Date:  2022-02-22       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.